insights_auto
Why is TWST up 4.51%?
Dive Deeperchevron_right
TWST:NASDAQ
Twist Bioscience Corp
$149.13
arrow_upward
+4.51%(+6.43) 1D
$149.01
arrow_downward
-0.08% (-0.12)bedtimeAfter hours
Closed: Oct 21, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
$139.34
High
$153.80
Low
$138.25
Mkt. cap
9.88B
Avg. vol.
2.84M
Volume
2.64M
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.22
Beta
2.19
Shares outstanding
65.83M
No. of employees
979
Open
$139.34
High
$153.80
Low
$138.25
Mkt. cap
9.88B
Avg. vol.
2.84M
Volume
2.64M
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.22
Beta
2.19
Shares outstanding
65.83M
No. of employees
979
News stories
From web sources and news partners
ad-hoc-news.de
·
1 day ago
TD Cowen lifts target to USD 190 for Twist Bioscience stock
Simply Wall Street
·
1 day ago
Is Twist Bioscience (TWST) Too Rich Or Still Reasonable On Sales?
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp